Evaxion Biotech A/S

📍 Hørsholm, Denmark🗓 Founded 2008👥 62 employees💰 Last funded Jun 2020
Biotechnology Research🌐 evaxion.ai
Website LinkedIn
Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.
4
Total investors
0
Early stage
1
Mid stage
1
Late stage
2008
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Denmark
2
United States
2
Investor activity2013–2020 · investors recorded per year
20131201712018120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Evaxion Biotech A/S?
Evaxion Biotech A/S has 4 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Evaxion Biotech A/S last raise funding?
The most recent investment in Evaxion Biotech A/S recorded on gritt.io was in June 2020.
When was Evaxion Biotech A/S founded?
Evaxion Biotech A/S was founded in 2008.
What industry is Evaxion Biotech A/S in?
Evaxion Biotech A/S operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Evaxion Biotech A/S based?
Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.